At the news
? NEUTRALIMPACT 2/10 EFFECT filed Apr 15, 2026 at 00:15 ET
Lyell Immunopharma's S-3 shelf registration has become effective, allowing the resale of up to 1,952,360 shares by selling stockholders. The company will not receive proceeds from any sales under this registration.
- S-3 shelf registration effective as of April 14, 2026
- Enables resale of 1,952,360 shares of common stock by selling stockholders
- Shares were acquired in a private placement on March 6, 2026, at $25.61 per share
- Company will not receive any proceeds from resales under this registration
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access